Amarin Corp PLC (AMRN) income statement
AMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3061% above fair value
$11.26−0.01 (-0.09%)
Close on Nov 18, 2026Market cap $248.90MP/E –Yield –
Amarin Corp PLC income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 40.9%
- Operating margin
- -18.2%
- Net margin
- -10.9%
- Return on equity, FY2025
- -8.2%
Financial strength
- Current ratio
- 3.50
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 89.4%
Valuation
- P/E ratio
- –
- Price to sales
- 1.41
- Price to book
- 0.56
- Dividend yield
- –
See a number that looks wrong?